Leslie Trigg Sells 65,236 Shares of Outset Medical, Inc. (NASDAQ:OM) Stock

Outset Medical, Inc. (NASDAQ:OM) CEO Leslie Trigg sold 65,236 shares of the company’s stock in a transaction dated Tuesday, January 21st. The stock was sold at an average price of $0.80, for a total transaction of $52,188.80. Following the transaction, the chief executive officer now owns 895,580 shares of the company’s stock, valued at approximately $716,464. This trade represents a 6.79 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Leslie Trigg also recently made the following trade(s):

• On Monday, January 13th, Leslie Trigg sold 33,227 shares of Outset Medical stock. The stock was sold at an average price of $0.81, for a total value of $26,913.87.
• On Tuesday, January 7th, Leslie Trigg sold 10,227 shares of Outset Medical stock. The shares were sold at an average price of $1.29, for a total value of $13,192.83.
• On Friday, November 15th, Leslie Trigg sold 5,645 shares of Outset Medical stock. The stock was sold at an average price of $0.80, for a total value of $4,516.00.

Outset Medical Trading Up 10.3 %

Shares of Outset Medical stock opened at $0.86 on Friday. The company has a debt-to-equity ratio of 4.12, a current ratio of 6.49 and a quick ratio of 5.04. The stock’s 50 day simple moving average is $1.01 and its 200-day simple moving average is $1.28. The stock has a market cap of $45.18 million, a P/E ratio of -0.31 and a beta of 2.05. Outset Medical, Inc. has a 1-year low of $0.44 and a 1-year high of $5.22.

Hedge Funds Weigh In On Outset Medical

A number of institutional investors have recently added to or reduced their stakes in OM. National Bank of Canada FI boosted its holdings in Outset Medical by 79.2% in the 3rd quarter. National Bank of Canada FI now owns 52,407 shares of the company’s stock valued at $35,000 after purchasing an additional 23,164 shares during the last quarter. Huntington National Bank lifted its holdings in Outset Medical by 46.2% in the third quarter. Huntington National Bank now owns 63,306 shares of the company’s stock valued at $43,000 after acquiring an additional 20,000 shares during the last quarter. GSA Capital Partners LLP lifted its holdings in Outset Medical by 924.7% in the third quarter. GSA Capital Partners LLP now owns 1,111,612 shares of the company’s stock valued at $753,000 after acquiring an additional 1,003,135 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new position in Outset Medical in the second quarter worth approximately $259,000. Finally, Point72 Asset Management L.P. acquired a new stake in Outset Medical during the second quarter worth $827,000.

Analyst Ratings Changes

Separately, Royal Bank of Canada reaffirmed a “sector perform” rating and set a $3.00 target price on shares of Outset Medical in a research note on Tuesday, January 7th.

About Outset Medical

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.